SCYNEXIS Announces FDA Acceptance and Priority Review of New Drug Application for Oral Ibrexafungerp for the Treatment of Vaginal Yeast Infections
Stock Information for SCYNEXIS Inc.
Loading
Please wait while we load your information from QuoteMedia.